# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-17-252789
Filing Date
2017-08-09
Accepted
2017-08-09 16:13:12
Documents
39
Period of Report
2017-08-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d398795d8k.htm | 8-K | 14726
2 | EX-99.1 | d398795dex991.htm | EX-99.1 | 19535
3 | EX-99.2 | d398795dex992.htm | EX-99.2 | 29731
4 | GRAPHIC | g398795ex99_2s10g1.jpg | GRAPHIC | 383337
5 | GRAPHIC | g398795ex99_2s11g1.jpg | GRAPHIC | 155052
6 | GRAPHIC | g398795ex99_2s12g1.jpg | GRAPHIC | 336369
7 | GRAPHIC | g398795ex99_2s13g1.jpg | GRAPHIC | 342150
8 | GRAPHIC | g398795ex99_2s14g1.jpg | GRAPHIC | 214230
9 | GRAPHIC | g398795ex99_2s15g1.jpg | GRAPHIC | 367477
10 | GRAPHIC | g398795ex99_2s16g1.jpg | GRAPHIC | 293625
11 | GRAPHIC | g398795ex99_2s17g1.jpg | GRAPHIC | 419395
12 | GRAPHIC | g398795ex99_2s18g1.jpg | GRAPHIC | 212497
13 | GRAPHIC | g398795ex99_2s19g1.jpg | GRAPHIC | 371769
14 | GRAPHIC | g398795ex99_2s1g1.jpg | GRAPHIC | 178994
15 | GRAPHIC | g398795ex99_2s20g1.jpg | GRAPHIC | 295401
16 | GRAPHIC | g398795ex99_2s21g1.jpg | GRAPHIC | 164721
17 | GRAPHIC | g398795ex99_2s22g1.jpg | GRAPHIC | 362640
18 | GRAPHIC | g398795ex99_2s23g1.jpg | GRAPHIC | 299862
19 | GRAPHIC | g398795ex99_2s24g1.jpg | GRAPHIC | 495128
20 | GRAPHIC | g398795ex99_2s25g1.jpg | GRAPHIC | 151188
21 | GRAPHIC | g398795ex99_2s26g1.jpg | GRAPHIC | 403693
22 | GRAPHIC | g398795ex99_2s27g1.jpg | GRAPHIC | 117102
23 | GRAPHIC | g398795ex99_2s28g1.jpg | GRAPHIC | 364365
24 | GRAPHIC | g398795ex99_2s29g1.jpg | GRAPHIC | 295064
25 | GRAPHIC | g398795ex99_2s2g1.jpg | GRAPHIC | 443405
26 | GRAPHIC | g398795ex99_2s30g1.jpg | GRAPHIC | 302471
27 | GRAPHIC | g398795ex99_2s31g1.jpg | GRAPHIC | 395692
28 | GRAPHIC | g398795ex99_2s32g1.jpg | GRAPHIC | 369189
29 | GRAPHIC | g398795ex99_2s33g1.jpg | GRAPHIC | 335995
30 | GRAPHIC | g398795ex99_2s34g1.jpg | GRAPHIC | 453720
31 | GRAPHIC | g398795ex99_2s35g1.jpg | GRAPHIC | 272412
32 | GRAPHIC | g398795ex99_2s3g1.jpg | GRAPHIC | 294514
33 | GRAPHIC | g398795ex99_2s4g1.jpg | GRAPHIC | 238755
34 | GRAPHIC | g398795ex99_2s5g1.jpg | GRAPHIC | 456168
35 | GRAPHIC | g398795ex99_2s6g1.jpg | GRAPHIC | 338434
36 | GRAPHIC | g398795ex99_2s7g1.jpg | GRAPHIC | 312501
37 | GRAPHIC | g398795ex99_2s8g1.jpg | GRAPHIC | 347963
38 | GRAPHIC | g398795ex99_2s9g1.jpg | GRAPHIC | 452112
39 | GRAPHIC | g398795g0809220035691.jpg | GRAPHIC | 3262
| Complete submission text file | 0001193125-17-252789.txt |  | 15549797

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 171018016
SIC: 2834 Pharmaceutical Preparations